The Appeal. The document.

By On 3. October 2012 · 1 Comment · In BioPorto

Deactivate | Edit

 

About Karl M. Bidstrup

Tidligere ejer af Medicoinvestor.com Strategien har gennem mange år været at profitere på etablerede aktier, og brænde det hele af på Bioporto... Sad but true. Kontakt mig på medicoinvestor(A)gmail.com hvis du har en million du ikke ved hvor du skal gemme, så skal jeg nok holde den for dig. 🙂

Related posts:

  1. Applicant Arguments on the USPTO non-final rejection of the “NGAL exclusion patent” application. (Page 1) ...
  2. The Appeal.  ...
  3. What is NGAL, and what’s its use? (Youtube Video) ...
  4. Bioporto VS Phadia. Dommen fra Sø&Handelsretten. Udskrift fra Sø&Handelsrettens Dombog. DOM Afsagt den 15. juni 2012 T-9-07 BioPorto Diagnostics...
  5. NGAL – en akut nyreparameter – Validering og opsætning af NGAL på Roche Modular P Kilde: NGAL – en akut nyreparameter- Validering og opsætning af...
 

One Response to The Appeal. The document.

  1. stengaard says:
    5. October 2012 at 12:17

    browsing through the Appeal – one is quite surprised to find not only obvious mistakes by the OD regarding the number of patients included – but perhaps more surprising the accusation of falsified documents !!!! Alledegly the opponents have added data to an exixting figure – in order to prove a point. If true – then that is a disgrace – and one would hope that legal action is taken

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.